|
Add the following:
» Sodium Bromide Injection, Veterinary contains an amount of Sodium Bromide equivalent to not less than 21.0 mg and not more than 25.6 mg of bromide (Br
Dissolve an accurately weighed quantity of Sodium Bromide in Sterile Water for Injection to volume with mixing. Sterilize by a suitable means such as sterile filtration or autoclaving.
Packaging and storage
Preserve in single-dose containers, preferably of Type I glass, and store in a refrigerator.
Labeling
Label it to indicate that it is to be discarded after 180 days, to state that it is to be kept out of the reach of children, and to indicate the nominal content of sodium bromide in the Injection. Label it to indicate that it is for infusion only at a rate not to exceed 150 mg of sodium bromide per kg body weight per hour. Label it to indicate that it is for veterinary use only.
Beyond-use date:
180 days after the date on which it was compounded.
Bacterial endotoxins
Sterility
Other requirements
It meets the requirements under Injections
Assay
Trichloroacetic acid (TCA) solution
Dissolve a quantity of TCA in water to obtain a 20% (w/v) solution.
Gold chloride solution
Dissolve a quantity of gold chloride in water to obtain a 0.5% (w/v) solution.
Blank
Use water.
Bromide standard stock solution
Dissolve an accurately weighed quantity of USP Sodium Bromide RS in water to obtain a solution having a known concentration equivalent to about 20 mg of bromide per mL.
Standard preparations
Prepare four Standard preparation solutions of known concentrations of about 2.0 mg of bromide per mL, 1.0 mg of bromide per mL, 0.5 mg of bromide per mL, and 0.25 mg of bromide per mL, respectively, by diluting quantitatively the Bromide standard stock solution with the appropriate volumes of water.
Assay preparation
Dilute Injection, Veterinary quantitatively with water (1:19).
Procedure (see Spectrophotometry and Light Scattering
20C
in which C is the concentration, in mg per mL, of bromide in the Assay preparation as calculated from the regression line.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 3567
Pharmacopeial Forum: Volume No. 33(5) Page 949
|